SE8300736D0 - Novel pharmacologically active compounds - Google Patents

Novel pharmacologically active compounds

Info

Publication number
SE8300736D0
SE8300736D0 SE8300736A SE8300736A SE8300736D0 SE 8300736 D0 SE8300736 D0 SE 8300736D0 SE 8300736 A SE8300736 A SE 8300736A SE 8300736 A SE8300736 A SE 8300736A SE 8300736 D0 SE8300736 D0 SE 8300736D0
Authority
SE
Sweden
Prior art keywords
active compounds
pharmacologically active
novel pharmacologically
novel
compounds
Prior art date
Application number
SE8300736A
Other languages
English (en)
Inventor
A E Brendstrom
S A I Carlsson
B I M Kellsson
P L Lindberg
Original Assignee
Haessle Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Haessle Ab filed Critical Haessle Ab
Priority to SE8300736A priority Critical patent/SE8300736D0/sv
Publication of SE8300736D0 publication Critical patent/SE8300736D0/sv
Priority to DE3404610A priority patent/DE3404610A1/de
Priority to SE8400688A priority patent/SE8400688L/sv
Priority to JP59022067A priority patent/JPS59181277A/ja
Priority to DK59184A priority patent/DK59184A/da
Priority to NL8400446A priority patent/NL8400446A/nl
Priority to BE0/212366A priority patent/BE898880A/fr
Priority to FI840547A priority patent/FI840547A/fi
Priority to AT0043584A priority patent/AT386825B/de
Priority to FR8402093A priority patent/FR2543551B1/fr
Priority to NO840504A priority patent/NO840504L/no
Priority to GB08403540A priority patent/GB2134523B/en
Priority to IT47675/84A priority patent/IT1177553B/it
Priority to AU24456/84A priority patent/AU578891B2/en
Priority to ZA841011A priority patent/ZA841011B/xx
Priority to LU85209A priority patent/LU85209A1/fr
Priority to NZ207102A priority patent/NZ207102A/en
Priority to CH660/84A priority patent/CH666892A5/de
Priority to GB868610503A priority patent/GB8610503D0/en
Priority to GB08610790A priority patent/GB2174988B/en
Priority to SE8700498A priority patent/SE8700498D0/sv
Priority to SE8700499A priority patent/SE8700499L/sv
Priority to NO882001A priority patent/NO882001D0/no
Priority to US07/408,719 priority patent/US5039806A/en
Priority to CY1555A priority patent/CY1555A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/68—One oxygen atom attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/14—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/14—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals
    • C07D217/16—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/28—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
SE8300736A 1983-02-11 1983-02-11 Novel pharmacologically active compounds SE8300736D0 (sv)

Priority Applications (25)

Application Number Priority Date Filing Date Title
SE8300736A SE8300736D0 (sv) 1983-02-11 1983-02-11 Novel pharmacologically active compounds
DE3404610A DE3404610A1 (de) 1983-02-11 1984-02-09 Benzimidazolderivate, verfahren zu deren herstellung und sie enthaltende arzneimittel
SE8400688A SE8400688L (sv) 1983-02-11 1984-02-09 Nya farmakologiskt aktiva foreningar
CH660/84A CH666892A5 (de) 1983-02-11 1984-02-10 Pharmakologisch aktive verbindungen, die zur verhuetung und behandlung von magengeschwueren verwendbar sind.
NO840504A NO840504L (no) 1983-02-11 1984-02-10 Nye farmakologisk aktive forbindelser
ZA841011A ZA841011B (en) 1983-02-11 1984-02-10 Novel pharmacologically active compounds
NL8400446A NL8400446A (nl) 1983-02-11 1984-02-10 Farmaceutisch werkzame verbindingen, werkwijzen ter bereiding ervan alsmede samenstellingen, die deze verbindingen bevatten.
BE0/212366A BE898880A (fr) 1983-02-11 1984-02-10 Nouveaux benzimidazoles, preparations pharmaceutiques qui les contiennent et leur preparation
FI840547A FI840547A (fi) 1983-02-11 1984-02-10 Nya farmakologiskt aktiva foereningar.
AT0043584A AT386825B (de) 1983-02-11 1984-02-10 Verfahren zur herstellung von neuen benzimidazolderivaten und von deren salzen
FR8402093A FR2543551B1 (fr) 1983-02-11 1984-02-10 Benzimidapoles substitues, procede pour leur preparation et compositions pharmaceutiques les contenant, inhibant la secretion d'acide gastrique ou exercant un effet cytoprotecteur du tube digestif
JP59022067A JPS59181277A (ja) 1983-02-11 1984-02-10 新規な薬理学的に活性な化合物
GB08403540A GB2134523B (en) 1983-02-11 1984-02-10 Novel pharmacologically active compounds
IT47675/84A IT1177553B (it) 1983-02-11 1984-02-10 Composti farmacologicamente attivi per il trattamento di affezioni gastrointestinali e procedimento di preparazione
AU24456/84A AU578891B2 (en) 1983-02-11 1984-02-10 Substituted 2-pyridylobenzimidazole derivatives
DK59184A DK59184A (da) 1983-02-11 1984-02-10 Farmakologisk virksomme forbindelser og terapeutisk acceptable salte deraf
LU85209A LU85209A1 (de) 1983-02-11 1984-02-10 Benzimidazoles substitues,procede pour leur preparation et compositions pharmaceutiques les contenant,inhibant la secretion d'acide gastrique ou exercant un effet cytoprotecteur du tube digestif
NZ207102A NZ207102A (en) 1983-02-11 1984-02-10 Benzimidazole derivatives and pharmaceutical compositions
GB868610503A GB8610503D0 (en) 1983-02-11 1986-04-29 Pyridyl alkylthiobenzimidazole derivatives
GB08610790A GB2174988B (en) 1983-02-11 1986-05-02 Intermediates for pyridyl alkylthio-benzimidazole derivatives
SE8700498A SE8700498D0 (sv) 1983-02-11 1987-02-10 Novel pharmaceologically active compounds
SE8700499A SE8700499L (sv) 1983-02-11 1987-02-10 Nya farmakologiskt aktiva foreningar
NO882001A NO882001D0 (no) 1983-02-11 1988-05-06 Analogifremgangsmaate til fremstilling av farmakologisk aktive forbindelser.
US07/408,719 US5039806A (en) 1983-02-11 1989-09-18 Novel pharmacologically active compound pyridyl methylsulfinyl benzimidazole
CY1555A CY1555A (en) 1983-02-11 1991-03-22 Pyridyl alkylthio-benzimidazole derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8300736A SE8300736D0 (sv) 1983-02-11 1983-02-11 Novel pharmacologically active compounds

Publications (1)

Publication Number Publication Date
SE8300736D0 true SE8300736D0 (sv) 1983-02-11

Family

ID=20349994

Family Applications (3)

Application Number Title Priority Date Filing Date
SE8300736A SE8300736D0 (sv) 1983-02-11 1983-02-11 Novel pharmacologically active compounds
SE8700498A SE8700498D0 (sv) 1983-02-11 1987-02-10 Novel pharmaceologically active compounds
SE8700499A SE8700499L (sv) 1983-02-11 1987-02-10 Nya farmakologiskt aktiva foreningar

Family Applications After (2)

Application Number Title Priority Date Filing Date
SE8700498A SE8700498D0 (sv) 1983-02-11 1987-02-10 Novel pharmaceologically active compounds
SE8700499A SE8700499L (sv) 1983-02-11 1987-02-10 Nya farmakologiskt aktiva foreningar

Country Status (19)

Country Link
US (1) US5039806A (sv)
JP (1) JPS59181277A (sv)
AT (1) AT386825B (sv)
AU (1) AU578891B2 (sv)
BE (1) BE898880A (sv)
CH (1) CH666892A5 (sv)
CY (1) CY1555A (sv)
DE (1) DE3404610A1 (sv)
DK (1) DK59184A (sv)
FI (1) FI840547A (sv)
FR (1) FR2543551B1 (sv)
GB (3) GB2134523B (sv)
IT (1) IT1177553B (sv)
LU (1) LU85209A1 (sv)
NL (1) NL8400446A (sv)
NO (1) NO840504L (sv)
NZ (1) NZ207102A (sv)
SE (3) SE8300736D0 (sv)
ZA (1) ZA841011B (sv)

Families Citing this family (110)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8300736D0 (sv) * 1983-02-11 1983-02-11 Haessle Ab Novel pharmacologically active compounds
CA1259070A (en) * 1983-07-01 1989-09-05 Upjohn Company (The) Substituted 2-¬monoannelated(3,4-,4,5-, and 5,6-)- pyridylalkylenesulfinyl|-benzimidazoles
US5077407A (en) * 1983-07-01 1991-12-31 The Upjohn Company Substituted 2-[monoannelated (3,4-,4,5-, and 5,6-) pyridylalkylenesulfinyl]benzimidazoles
US4575554A (en) * 1983-12-05 1986-03-11 The Upjohn Company Substituted 2-pyridylmethylthio- and sulfinyl-benzimidazoles as gastric antisecretory agents
ZW4585A1 (en) * 1984-04-19 1985-11-20 Hoffmann La Roche Imidazole derivatives
CA1341314C (en) 1984-07-06 2001-11-06 David Cox Derivatives of benzimidazole, benzothiazole and benzoxazole
SE8404065D0 (sv) * 1984-08-10 1984-08-10 Haessle Ab Novel biologically active compounds
JPS6150979A (ja) * 1984-08-16 1986-03-13 Takeda Chem Ind Ltd ピリジン誘導体およびその製造法
JPS6150978A (ja) * 1984-08-16 1986-03-13 Takeda Chem Ind Ltd ピリジン誘導体およびその製造法
US4619997A (en) * 1984-09-06 1986-10-28 The Upjohn Company Substituted 2-pyridylmethylthio and sulfinyl-benzimidazoles as gastric antisecretory agents
AU568441B2 (en) * 1984-09-24 1987-12-24 Upjohn Company, The 2-(pyridylalkenesulfinyl) benzimidazole derivatives
KR890000387B1 (ko) * 1984-09-24 1989-03-16 디 엎존 캄파니 2-(피리딜알켄술 피닐)벤즈 이미드아졸류의 n-치환 유도체의 제조방법
IL76839A (en) * 1984-10-31 1988-08-31 Byk Gulden Lomberg Chem Fab Picoline derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
DE3509333A1 (de) * 1985-03-15 1986-09-18 Hoechst Ag, 6230 Frankfurt Substituierte benzimidazolderivate, verfahren zu ihrer herstellung, sie enthaltende pharmazeutische zubereitungen und ihre verwendung als magensaeuresekretionshemmer
AU5768886A (en) 1985-05-24 1986-11-27 G.D. Searle & Co. 2-((1-h-benzimidazol-2-ylsulfinyl)methyl)benzenamines
US5869513A (en) * 1985-05-24 1999-02-09 G. D. Searle & Co. 2- (1H-benzimidazol-2-ylsulfinyl)methyl!benzenamines
US4738975A (en) * 1985-07-02 1988-04-19 Takeda Chemical Industries, Ltd. Pyridine derivatives, and use as anti-ulcer agents
DK337086A (da) * 1985-08-12 1987-02-13 Hoffmann La Roche Benzimidazolderivater
SE8505112D0 (sv) * 1985-10-29 1985-10-29 Haessle Ab Novel pharmacological compounds
US5433959A (en) 1986-02-13 1995-07-18 Takeda Chemical Industries, Ltd. Stabilized pharmaceutical composition
US6749864B2 (en) 1986-02-13 2004-06-15 Takeda Chemical Industries, Ltd. Stabilized pharmaceutical composition
CA1327010C (en) * 1986-02-13 1994-02-15 Tadashi Makino Stabilized solid pharmaceutical composition containing antiulcer benzimidazole compound and its production
EP0234485B1 (de) * 1986-02-20 1992-04-01 Hoechst Aktiengesellschaft Substituierte Thienoimidazol-Derivate, Verfahren zu ihrer Herstellung, sie enthaltende pharmazeutische Zubereitungen und ihre Verwendung als Magensäuresekretionshemmer
JPS62201884A (ja) * 1986-02-28 1987-09-05 Tokyo Tanabe Co Ltd ベンズイミダゾール誘導体及びその製造法
ATE56717T1 (de) * 1986-07-01 1990-10-15 Shionogi & Co Substituierte isoquinolinderivate und antiulcusmittel.
US4772619A (en) * 1986-07-17 1988-09-20 G. D. Searle & Co. [(1H-benzimidazol-2-ylsulfinyl)methyl]-2-pyridinamines
US4687775A (en) * 1986-07-17 1987-08-18 G. D. Searle & Co. 2-[(Imidazo[1,2-a]pyridinylmethyl)sulfinyl]-1H-benzimidazoles
US4721718A (en) * 1986-08-18 1988-01-26 G. D. Searle & Co. 2-[(imidazo[1,2-a]pyridin-3-ylmethyl)sulfinyl]-1H-benzimidazoles useful in the treatment and prevention of ulcers
SE8604566D0 (sv) * 1986-10-27 1986-10-27 Haessle Ab Novel compunds
ATE103912T1 (de) * 1986-11-13 1994-04-15 Eisai Co Ltd Pyridin-derivate, deren pharmazeutische zusammenstellungen, deren anwendung fuer die herstellung von arzneimitteln mit therapeutischem oder vorbeugendem wert und verfahren zu deren herstellung.
FI90544C (sv) * 1986-11-13 1994-02-25 Eisai Co Ltd Förfarande för framställning såsom läkemedel användbara 2-pyridin-2-yl-metyltio- och sulfinyl-1H-benzimidazolderivater
NZ222495A (en) * 1986-11-21 1991-04-26 Haessle Ab Benzimidazole derivatives and pharmaceutical compositions
US5026560A (en) * 1987-01-29 1991-06-25 Takeda Chemical Industries, Ltd. Spherical granules having core and their production
US4942245A (en) * 1987-04-20 1990-07-17 Kyorin Pharmaceutical Co., Ltd. Benzimidazole Derivatives
US4839365A (en) * 1987-05-19 1989-06-13 Shinogi & Co., Ltd. Thienopyridine derivatives useful in treating gastric ulcers
JP2718945B2 (ja) * 1987-06-17 1998-02-25 エーザイ株式会社 ピリジン誘導体及びそれを含有する潰瘍治療剤
FI96860C (sv) * 1987-06-17 1996-09-10 Eisai Co Ltd Ett analogiförfarande för framställning av ett som läkemedel avsett pyridinderivat
US4920230A (en) * 1987-06-29 1990-04-24 Takeda Chemical Industries, Ltd. Method of producing nitrogen-containing heteroaromatic compounds having an alkoxy group
WO1989000566A1 (en) * 1987-07-21 1989-01-26 Yoshitomi Pharmaceutical Industries, Ltd. Pyridine compounds and medicinal use thereof
WO1990003373A1 (en) * 1988-09-20 1990-04-05 Hisamitsu Pharmaceutical Co., Inc. NOVEL DIBENZ[b,e]OXEPIN DERIVATIVES
AT391693B (de) * 1988-11-15 1990-11-12 Cl Pharma Verfahren zur herstellung von 3-5-dimethyl-4methoxypyridinderivaten sowie neues zwischenprodukt hierfuer
EG19302A (en) * 1988-12-22 1994-11-30 Haessle Ab Compound with gastric acid inhibitory effect and process for its preparation
US4965269A (en) * 1989-12-20 1990-10-23 Ab Hassle Therapeutically active chloro substituted benzimidazoles
SE9002043D0 (sv) * 1990-06-07 1990-06-07 Astra Ab Improved method for synthesis
SE9002206D0 (sv) 1990-06-20 1990-06-20 Haessle Ab New compounds
EP0567643A4 (en) * 1991-01-16 1995-07-19 Yoshitomi Pharmaceutical PYRIDINE COMPOUND USED AS A SELECTIVE DRUG AND NEW PYRIDINE COMPOUND.
ES2037609B1 (es) * 1991-12-02 1994-04-01 Techquin Etablissment Procedimiento para la obtencion del 2-(((3-metil-4-(2,2,2-trifluroetoxi)-2-piridinil)-metil)sulfinil)-1h-benzimidazol.
ES2037608B1 (es) * 1991-12-02 1994-04-01 Techquin Etablissment Procedimiento para la obtencion del 2 (((3-metil-4-(2,2,2,-trifluoroetoxi)-2-piridinil)-metil)sulfinil)-1h-benzimidazol".
US5504082A (en) * 1992-06-01 1996-04-02 Yoshitomi Pharmaceutical Industries, Ltd. Pyridine compound and pharmaceutical compostions
KR950701921A (ko) * 1992-06-01 1995-05-17 고야 다다시 피리딘 화합물 및 이의 제약학적 용도(pyridine compound and medicinal use thereof)
KR0144793B1 (ko) * 1992-07-08 1998-07-15 제임스 클리프튼 보올딩 돼지에서 위궤양을 완화시키기 위한 벤즈이미다졸
HU226778B1 (en) * 1992-07-28 2009-10-28 Astra Ab Injection and injection kit containing omeprazole and its analogs
TW280770B (sv) 1993-10-15 1996-07-11 Takeda Pharm Industry Co Ltd
CA2178000A1 (en) 1993-12-01 1995-06-08 Jorg Senn-Bilfinger Substituted aminoalkylaminopyridines
KR0142815B1 (ko) * 1994-12-02 1998-07-15 정도언 신규한 5-피롤릴-6-할로게노-2피리딜메틸설피닐벤즈이미다졸 유도체
KR0179401B1 (ko) * 1994-02-28 1999-03-20 송택선 신규한 5-피롤릴-2-피리딜메틸설피닐벤즈이미다졸 유도체
WO1995029897A1 (en) * 1994-04-29 1995-11-09 G.D. Searle & Co. METHOD OF USING (H+/K+) ATPase INHIBITORS AS ANTIVIRAL AGENTS
HUT76054A (en) * 1994-06-10 1997-06-30 Byk Gulden Lomberg Chem Fab Thiopyridines, pharmaceutical compositions containing them, process for producing them and their use in the control of helicobacter bacteria
NZ318501A (en) * 1995-09-21 1999-06-29 Pharma Pass Llc Novel composition containing an acid-labile omeprazole and process for its preparation
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US6489346B1 (en) * 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US6645988B2 (en) * 1996-01-04 2003-11-11 Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US6699885B2 (en) 1996-01-04 2004-03-02 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and methods of using same
US7230014B1 (en) 1997-10-14 2007-06-12 Eisai Co., Ltd. Pharmaceutical formulation comprising glycine as a stabilizer
JP3746167B2 (ja) 1998-05-18 2006-02-15 武田薬品工業株式会社 医薬製剤
US6093734A (en) * 1998-08-10 2000-07-25 Partnership Of Michael E. Garst, George Sachs, And Jai Moo Shin Prodrugs of proton pump inhibitors
ID28273A (id) * 1998-08-10 2001-05-10 Partnership Of Michael E Garst Prodrug inhibitor pompa proton
WO2000027841A1 (en) * 1998-11-06 2000-05-18 Dong-A Pharmaceutical Co., Ltd. Method of preparing sulfide derivatives
US6245913B1 (en) 1999-06-30 2001-06-12 Wockhardt Europe Limited Synthetic procedure for 5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methylthio]-IH-benzimidazole hydrochloride and its conversion to omeprazole
US6262085B1 (en) * 1999-08-26 2001-07-17 Robert R. Whittle Alkoxy substituted Benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
EP1595879A3 (en) * 1999-08-26 2010-01-27 aaiPharma Inc. Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
RU2263673C2 (ru) * 1999-08-26 2005-11-10 ааиФАРМА ИНК. Алкоксизамещенные бензимидазольные соединения, содержащие их фармацевтические препараты и способ их применения
US6369087B1 (en) * 1999-08-26 2002-04-09 Robert R. Whittle Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US6780880B1 (en) 1999-08-26 2004-08-24 Robert R. Whittle FT-Raman spectroscopic measurement
MXPA02008232A (es) 2000-02-24 2004-04-05 Kopran Res Lab Ltd Derivados de benximidazol contra ulceras, estables al acido, administrables por via oral.
US6544556B1 (en) * 2000-09-11 2003-04-08 Andrx Corporation Pharmaceutical formulations containing a non-steroidal antiinflammatory drug and a proton pump inhibitor
AU2001296908A1 (en) * 2000-09-29 2002-04-08 Geneva Pharmaceuticals, Inc. Proton pump inhibitor formulation
KR20040029966A (ko) * 2001-02-02 2004-04-08 테바 파마슈티컬 인더스트리즈 리미티드 치환된 2-(2-피리딜메틸)설피닐-１ｈ-벤즈이미다졸
US6903126B2 (en) * 2001-07-09 2005-06-07 Schering Ag 1-Aryl-2-N-, S- or O-substituted benzimidazole derivatives, their use for the production of pharmaceutical agents as well as pharmaceutical preparations that contain these derivatives
DE10135050A1 (de) * 2001-07-09 2003-02-06 Schering Ag 1-Ary1-2-N-, S- oder O-substituierte Benzimidazolderivate, deren Verwendung zur Herstellung von Arzneimitteln sowie diese Derivate enthaltende pharmazeutische Präparate
US20040248941A1 (en) * 2001-09-25 2004-12-09 Keiji Kamiyama Benzimidazone compound, process for producing the same, and use thereof
US20040006111A1 (en) * 2002-01-25 2004-01-08 Kenneth Widder Transmucosal delivery of proton pump inhibitors
US20030228363A1 (en) * 2002-06-07 2003-12-11 Patel Mahendra R. Stabilized pharmaceutical compositons containing benzimidazole compounds
US7410981B2 (en) * 2002-06-14 2008-08-12 Takeda Pharmaceutical Company Limited Prodrugs of imidazole derivatives, for use as proton pump inhibitors in the treatment of e.g. peptic ulcers
EP1572680A2 (en) 2002-12-19 2005-09-14 Eva Pharmaceutical Industries Ltd. Solid states of pantoprazole sodium, known pantoprazole sodium hydrates, processes for their preparation.
ES2324665T3 (es) * 2003-01-15 2009-08-12 Cipla Limited Proceso farmaceutico y compuestos preparados a traves del mismo.
CA2517005A1 (en) * 2003-02-20 2004-09-02 Santarus, Inc. A novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid
MXPA05013316A (es) 2003-06-10 2006-03-17 Teva Pharma Proceso para preparar bencimidazoles 2[-(piridinil)metil]sulfinil-sustituidos y derivados clorados novedosos de pantoprazol.
PL379542A1 (pl) * 2003-07-15 2006-10-02 Allergan, Inc. Sposób wytwarzania izomerycznie czystych proleków inhibitorów pompy protonowej
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
AR046893A1 (es) * 2003-12-16 2005-12-28 Altana Pharma Ag Bencimidazoles triciclicos
TW200606163A (en) 2004-04-22 2006-02-16 Eisai Co Ltd Imidazopyridine compound
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8815916B2 (en) 2004-05-25 2014-08-26 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US20060024362A1 (en) 2004-07-29 2006-02-02 Pawan Seth Composition comprising a benzimidazole and process for its manufacture
US8592598B2 (en) 2004-09-13 2013-11-26 Takeda Pharmaceutical Company Limited Method of producing a crystal of an imidazole compound
US20070015782A1 (en) * 2005-04-15 2007-01-18 Eisai Co., Ltd. Benzimidazole compound
MY151167A (en) * 2005-04-15 2014-04-30 Eisai R&D Man Co Ltd Benzimidazole compound
US9040564B2 (en) 2005-04-28 2015-05-26 Eisai R&D Management Co., Ltd. Stabilized composition
JP5053865B2 (ja) 2005-12-28 2012-10-24 武田薬品工業株式会社 口腔内崩壊性固形製剤の製造法
WO2007122686A1 (ja) * 2006-04-14 2007-11-01 Eisai R & D Management Co., Ltd. ベンズイミダゾール化合物
US7786309B2 (en) * 2006-06-09 2010-08-31 Apotex Pharmachem Inc. Process for the preparation of esomeprazole and salts thereof
JP5492417B2 (ja) * 2006-10-13 2014-05-14 エーザイ・アール・アンド・ディー・マネジメント株式会社 胃酸分泌抑制作用を有するベンズイミダゾール化合物
AU2007335663B2 (en) 2006-12-18 2011-12-15 Link Genomics, Inc. Helicobacter pylori eradicating agent having inhibitory activity on gastric acid secretion
ZA200904573B (en) 2006-12-22 2010-09-29 Ironwood Pharmaceuticals Inc Compositions comprising bile acid sequestrants for treating esophageal disorders
CN102140099A (zh) * 2010-02-02 2011-08-03 山东轩竹医药科技有限公司 新的吡啶衍生物
WO2012027331A1 (en) 2010-08-27 2012-03-01 Ironwood Pharmaceuticals, Inc. Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders
CN105338958A (zh) 2013-01-15 2016-02-17 铁木医药有限公司 胆汁酸螯合剂的胃内滞留缓释口服剂型
WO2016126625A1 (en) 2015-02-03 2016-08-11 Ironwood Pharmaceuticals, Inc. Methods of treating upper gastrointestinal disorders in ppi refractory gerd
IL265108B2 (en) * 2016-09-14 2024-03-01 Yufeng Jane Tseng Novel mutated benzimidazoles as D-amino acid oxidase (DAAO) inhibitors

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1013069B (it) * 1973-03-29 1977-03-30 Du Pont Processo di preparazione di 2 benzimidazoltiolo
US3857769A (en) * 1973-11-08 1974-12-31 Scm Corp Photopolymerizable coating compositions and process for making same which contains a thioxanthone and an activated halogenated azine compound as sensitizers
SE418966B (sv) * 1974-02-18 1981-07-06 Haessle Ab Analogiforfarande for framstellning av foreningar med magsyrasekretionsinhiberande verkan
US4045564A (en) * 1974-02-18 1977-08-30 Ab Hassle Benzimidazole derivatives useful as gastric acid secretion inhibitors
SE416649B (sv) * 1974-05-16 1981-01-26 Haessle Ab Forfarande for framstellning av foreningar som paverkar magsyrasekretionen
SE7804231L (sv) * 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
HU178454B (en) * 1979-07-02 1982-05-28 Chinoin Gyogyszer Es Vegyeszet Process for preparing new isoquinoline derivatives containing sulphur
NL8002540A (nl) * 1979-05-09 1980-11-11 Rhone Poulenc Ind Nieuwe isochinoline derivaten, werkwijzen ter bereiding ervan en farmaceutische preparaten, die de nieuwe derivaten bevatten.
US4359465A (en) * 1980-07-28 1982-11-16 The Upjohn Company Methods for treating gastrointestinal inflammation
CH644116A5 (de) * 1980-08-21 1984-07-13 Hoffmann La Roche Imidazolderivate.
IL66340A (en) * 1981-08-13 1986-08-31 Haessle Ab Pharmaceutical compositions comprising pyridylmethyl-thiobenzimidazole derivatives,certain such novel derivatives and their preparation
US4472409A (en) * 1981-11-05 1984-09-18 Byk Gulden Lomberg Chemische Fabrik Gesellschaft Mit Beschrankter Haftung 2-Pyridylmethyl thio(sulfinyl)benzimidazoles with gastric acid secretion inhibiting effects
SE8300736D0 (sv) * 1983-02-11 1983-02-11 Haessle Ab Novel pharmacologically active compounds
JPS6150979A (ja) * 1984-08-16 1986-03-13 Takeda Chem Ind Ltd ピリジン誘導体およびその製造法

Also Published As

Publication number Publication date
DK59184A (da) 1984-08-12
SE8700498L (sv) 1987-02-10
IT8447675A0 (it) 1984-02-10
LU85209A1 (de) 1985-09-12
CH666892A5 (de) 1988-08-31
GB8403540D0 (en) 1984-03-14
AU578891B2 (en) 1988-11-10
DK59184D0 (da) 1984-02-10
GB8610503D0 (en) 1986-06-04
SE8700499D0 (sv) 1987-02-10
AT386825B (de) 1988-10-25
NL8400446A (nl) 1984-09-03
GB2134523A (en) 1984-08-15
NZ207102A (en) 1987-09-30
US5039806A (en) 1991-08-13
NO840504L (no) 1984-08-13
FI840547A0 (fi) 1984-02-10
DE3404610A1 (de) 1984-08-16
GB2134523B (en) 1987-08-12
JPS59181277A (ja) 1984-10-15
SE8700498D0 (sv) 1987-02-10
ATA43584A (de) 1988-03-15
GB8610790D0 (en) 1986-06-11
AU2445684A (en) 1984-08-16
GB2174988A (en) 1986-11-19
BE898880A (fr) 1984-08-10
FR2543551A1 (fr) 1984-10-05
GB2174988B (en) 1987-08-26
FR2543551B1 (fr) 1987-08-21
ZA841011B (en) 1984-09-26
IT1177553B (it) 1987-08-26
FI840547A (fi) 1984-08-12
CY1555A (en) 1991-03-22
SE8700499L (sv) 1987-02-10

Similar Documents

Publication Publication Date Title
SE8300736D0 (sv) Novel pharmacologically active compounds
SE8505112D0 (sv) Novel pharmacological compounds
IE862554L (en) Pharmaceutical compositions
ES2095432T3 (es) Derivados de 2,4-tiazolidin-diona, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
ES2074846T3 (es) Nuevas naftil-etil-ureas y naftil-etil-tioureas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen.
KR890700125A (ko) 신규 벤즈이미다졸 유도체, 그 제조방법 및 이 화합물을 함유하는 제약 조성물
ES2097297T3 (es) Isoquinolein-5-il-sulfonamidas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen.
SE8600658D0 (sv) Novel composition of matter
SE8405588D0 (sv) New compounds
SE8302979L (sv) Piperazinderivat, deras framstellning och farmaceutiska kompositioner innehallande dessa
SE8306225L (sv) 2-piperazinyl-kinazolinderivat, deras framstellning och farmaceutiska kompositioner innehallande desamma
NZ220800A (en) Tetrahydrobenzothiazoles and pharmaceutical compositions
DK0418990T3 (da) 13-brom- og 13,14-dibrom-ergoliner, deres fremstilling og anvendelse i lægemidler
IL67400A0 (en) 3,7alpha-diazacyclohepta(j,k)fluorene derivatives,their preparation and pharmaceutical compositions containing them
SE8704049D0 (sv) Novel pharmacological compounds
JO1519B1 (en) New compounds (new benzimidazole derivatives are effective as ulcers)